Healthtech Startups

Bbiyak is a mobile application that helps users manage GLP-1 obesity treatment through tracking weight loss, injection dosages, appetite control, and exercise. The app serves people using weight loss injections (semaglutide, liraglutide, tirzepatide) in South Korea and includes a community forum for sharing experiences and tips.

2 investors

APITbio develops antibody-based therapeutics using a proprietary fully human antibody library, with platforms for antibody discovery, engineering, optimization, production, and bispecific antibody creation. Its pipeline includes monoclonal antibodies, bispecific antibodies, and a CAR-T program under joint research.

2 investors

L&K Biomed develops spinal medical devices and related surgical products. The company focuses on research and development of orthopedic and spine healthcare technology.

2 investors

Ubix Therapeutics (주식회사 유빅스테라퓨틱스) is a South Korean company whose services include a health-management offering that processes health data such as blood oxygen saturation, blood glucose, blood pressure, heart rate, height, and weight. The page reviewed is a privacy policy and gives limited detail about the company's core business.

2 investors

PNTbiz operates IndoorPlus+, a real-time location and asset tracking platform that uses RTLS, location-based services, and smart sensing technologies for indoor monitoring and navigation. The platform serves hospitals, enterprises, and industrial facilities for applications including worker safety, asset management, access control, and environmental monitoring.

2 investors

Akari Hosho is a Japanese company that provides identity-guarantee and personal-surety services—acting as guarantor or joint surety for admission to medical institutions and care facilities, covering payment obligations, handling post-death affairs such as funerals and body collection, and managing clients' assets. It operates with a team of professionals including lawyers, judicial scriveners, nurses, and care managers, in compliance with government guidelines.

2 investors

ATLASTHEALTH, Inc. provides an online mental healthcare service in Japan that connects people with psychiatric conditions to online medical consultations, counseling, and return-to-work (reintegration) support as a single integrated system. The company aims to help patients access and continue treatment and re-enter the workforce, targeting people with mental disorders and employers dealing with workforce reintegration.

2 investors

IMMUNOSENS manufactures in vitro diagnostic pharmaceuticals and third-class medical devices for clinical diagnostic purposes. The company holds regulatory approvals from Japanese authorities for these medical products.

2 investors

Orizuru Therapeutics develops cellular therapy products and regenerative medicine treatments utilizing iPS cell-related technology. The company supports drug discovery research and establishes regenerative medicine research infrastructure for the Japanese healthcare and biotechnology sectors.

2 investors

A Japanese media and digital marketing company that operates video and SNS platforms focused on the elderly care sector, providing video production services for care facilities and a talent platform to support care workers.

2 investors

Cuorips develops regenerative medicine products based on human iPS cell technology, including its heart muscle cell sheet "Heart®" (Rehart) for treating severe heart failure caused by ischemic cardiomyopathy, along with catheter-based therapies and compound drugs (YS series). The Japan-based company, spun out of Osaka University research, also builds cell mass-manufacturing infrastructure (VMaCS) and is listed on the Tokyo Stock Exchange Growth market.

2 investors

Style Edge provides comprehensive business support services to professionals in the legal and medical fields, helping them address management challenges outside their core expertise. It combines online and offline services across five service lines to support these professionals in Japan.

2 investors

Solasia is a pharmaceutical company that in-licenses promising drug candidates from overseas and domestic pharma and biotech companies and develops them through clinical trials for the Japanese and Asian markets. Founded in 2006, it focuses on supplying cancer-related medicines to patients across Japan and other Asian countries.

2 investors

DoctorMate provides online medical support services to care facilities, offering 24/7 on-call backup from physicians and nurses, specialist consultations, and telemedicine for residents. The service is designed to reduce nurse workload and prevent unnecessary emergency transports at long-term care facilities.

2 investors

Trinity Technology (renamed Kokoro no Company as of April 2026) provides digital and AI-enabled services for Japan's aging society, addressing asset freezing from dementia, elder care management, inheritance procedures, business succession, and out-of-pocket care services. The company operates multiple service lines combining technology with personalized support for seniors and their families.

2 investors

A digital solutions company providing medical and healthcare information access for physicians, healthcare institutions, and pharmaceutical companies in Japan.

2 investors

NeuroSpace provides corporate sleep-improvement services for working professionals, including sleep seminars, a 7-week improvement program (Biz Sleep), sleep checks, and sleep apnea surveys. Founded in 2013, it serves companies and municipalities in Japan focused on employee health and well-being.

2 investors

BackTech develops Pocket Therapist, a digital platform connecting employees with physical therapists and health professionals to address musculoskeletal pain and wellness issues in workplace health management. The service uses technology to bridge employees and specialists across time and location for occupational health interventions.

2 investors

B.Dot Medical is a Japanese medical device startup developing and commercializing proton beam therapy systems for cancer treatment. Its stated goal is to make proton therapy—currently available to only a small share of patients—widely accessible to patients worldwide.

2 investors

BrightPath Bio develops novel cancer immunotherapy medicines and cell therapy treatments that enhance the body's natural immune response to eliminate cancer cells. The company builds a platform for developing cell and antibody therapeutics across different cancer types and target antigens, with plans to expand into other immune-modulation therapeutic areas.

2 investors

MedUp develops and provides medical/healthcare IT systems, including software supporting regional healthcare collaboration for medical institutions. The company operates in Japan's healthcare technology sector.

2 investors

Medeta develops AI and digital technology solutions to expand reproductive medicine techniques and services, making them reproducible and accessible to patients. The company applies artificial intelligence to fertility treatment workflows to enhance physician and embryologist expertise.

2 investors

TYK Medicines (同源康) is a Chinese biopharmaceutical company focused on discovering and developing innovative small-molecule drugs, with a platform for designing and screening targeted-therapy compounds. Its pipeline includes EGFR-targeting treatments for non-small cell lung cancer and brain metastases.

2 investors

AFI manufactures rapid microbial detection systems using flow cytometry and solid-phase cytometry technologies for quality control in pharmaceuticals, clinical diagnostics, cosmetics, food and beverage, and environmental testing.

2 investors